Form 4: Cytek Biosciences CEO Wenbin Jiang Reports Stock Transactions
SEC Form 4 Filing
Wenbin Jiang, CEO of Cytek Biosciences, reports the vesting and subsequent tax withholding of restricted stock units.
Summary
- On May 20, 2024, Wenbin Jiang, the President and CEO of Cytek Biosciences, engaged in transactions involving common stock and restricted stock units (RSUs).
- Jiang acquired shares through the vesting of RSUs and subsequently surrendered shares to the issuer to cover tax withholding obligations.
- Specifically, 6,758, 7,854, and 14,733 shares were acquired through RSU vesting.
- A total of 1,601, 1,913, and 3,588 shares were withheld to satisfy tax obligations at a price of $5.96 per share.
- Following these transactions, Jiang directly owns 5,326,154 shares of Cytek Biosciences common stock and holds 338,873 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/18/2022 | Initial vesting date for some of the RSU awards. |
| 05/18/2023 | Vesting date for some of the RSU awards. |
| 05/18/2024 | Vesting date for some of the RSU awards. |
| 05/20/2024 | Date of the reported transactions (RSU vesting and tax withholding). |
| 05/22/2024 | Date of the form filing. |
| 03/10/2025 | Future vesting date for some of the RSU awards. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.